Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)

Blood (2022) 140 (Supplement 2): LBA-3.

https://doi.org/10.1182/blood-2022-171733

Published: 2022

Journal Articles

High-Dose Chemotherapy and Autologous Stem Cell Transplant in Elderly and Fit Primary CNS Lymphoma Patients - a Multicenter Study By the Cooperative PCNSL Study Group (MARTA study)

Blood (2022) 140 (Supplement 1): 1773–1774.

https://doi.org/10.1182/blood-2022-162157

Published: 2022

Journal Articles

Prognostic Impact of Gastrointestinal Involvement in Newly Diagnosed Diffuse Large B-Cell Lymphoma

David Kasouha, Nicola Lehners, Katharina Kriegsmann, MD MBA, Gerlinde Egerer, Anthony D Ho, Mathias Witzens-Harig, MD

Blood (2018) 132 (Supplement 1): 5400.

https://doi.org/10.1182/blood-2018-99-117125

Published: 2018

Journal Articles

Characterization of Patients with Multiple Myeloma in Long- Term Remission

Raphael K. Lutz, MD, Katharina Kriegsmann, MD MBA, Mohamed H.S. Awwad, Carsten Müller-Tidow, MD, Gerlinde Egerer, Nicola Lehners, Marc S Raab, MD PhD, Brian GM Durie, MD, Michael Hundemer, Hartmut Goldschmidt, MD

Blood (2018) 132 (Supplement 1): 4508.

https://doi.org/10.1182/blood-2018-99-116039

Published: 2018

Journal Articles

Analysis of Risk Factors Regarding Short- and Long-Term Mortality of Critically Ill Patients with Hematologic Malignancies or Following Stem Cell Transplantation Requiring Treatment on the Intensive Care Unit

Timo Funk, Martin Schiller, Gerlinde Egerer, Carsten Müller-Tidow, Anthony D. Ho, Uta Merle, Nicola Lehners, MD

Blood (2017) 130 (Supplement 1): 1947.

https://doi.org/10.1182/blood.V130.Suppl_1.1947.1947

Published: 2017

Journal Articles

Prognostic Impact of Extranodal Involvement in Newly Diagnosed Diffuse Large B-Cell Lymphoma

David Kasouha, Nicola Lehners, MD, Katharina Kriegsmann, MD MBA, Gerlinde Egerer, Anthony D. Ho, Mathias Witzens-Harig, MD MHBA

Blood (2017) 130 (Supplement 1): 2855.

https://doi.org/10.1182/blood.V130.Suppl_1.2855.2855

Published: 2017

Journal Articles

High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Support for Relapsed or Refractory Primary CNS Lymphoma - a Prospective Multicentre Trial By the German Cooperative PCNSL Study Group

Blood (2016) 128 (22): 781.

https://doi.org/10.1182/blood.V128.22.781.781

Published: 2016

Journal Articles

Parainfluenza Virus Infections in Patients with Hematologic Malignancies or Following Stem Cell Transplantation: Analysis of Clinical Characteristics, Nosocomial Transmission and Prolonged Viral Shedding

Nicola Lehners, MD, Joe Puthenparambil, MD, Martin Schiller, MD, Anthony D. Ho, MD, Paul Schnitzler, MD, Gerlinde Egerer, MD

Blood (2016) 128 (22): 3401.

https://doi.org/10.1182/blood.V128.22.3401.3401

Published: 2016

Journal Articles

Analysis of Prognostic Factors and Outcome of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma of the Gastrointestinal Tract

Nicola Lehners, MD, Isabelle Kraemer, MD, Ronald Koschny, MD, Gerlinde Egerer, MD, Anthony D. Ho, MD, Mathias Witzens-Harig, MD

Blood (2015) 126 (23): 3964.

https://doi.org/10.1182/blood.V126.23.3964.3964

Published: 2015

Journal Articles

High Dose-Chemotherapy Followed By Autologous Peripheral Blood Stem Cell Transplantation for Patients with Refractory or Recurrent Primary Central Nervous System Lymphoma –Results of a Multicenter Study By the Germany Collaborative PCNSL Study Group

Gerald Illerhaus, MD, Kristina Fritsch, MD, Ingo Schmidt-Wolf, MD, Roland Schroers, MD, Gerlinde Egerer, MD, Agnieszka Korfel, MD, Tobias Birnbaum, MD, Monika Lamprecht, MD, Nikolas von Bubnoff, Hans-Heinrich Wolf, MD, Stephan Stilgenbauer, MD, Martin Trepel, MD PhD, Robert Möhle, MD, Claudia Hader, MD, Gabriele Ihorst, Heidi Fricker, Benjamin Kasenda, MD, Elisabeth Schorb, MD, Jürgen Finke, MD

Blood (2014) 124 (21): 2527.

https://doi.org/10.1182/blood.V124.21.2527.2527

Published: 2014

Journal Articles

Rituximab, Age and High Dose Therapy Followed By Autologus Stem Cell Transplantation Are Independent Prognostic Factors for Survival in the First Line Treatment of Primary CNS-Lymphoma

Michael Madle, Isabelle Herth, Nicola Lehners, MD, Mark-Alexander Schwarzbich, MD, Patrick Wuchter, Gerlinde Egerer, MD, Anthony D. Ho, Mathias Witzens-Harig, MD

Blood (2014) 124 (21): 1727.

https://doi.org/10.1182/blood.V124.21.1727.1727

Published: 2014

Journal Articles

Impact Of Response Duration and Maintenance Therapy After Autologous Stem Cell Transplantation On Long-Term Survival In Multiple Myeloma Patients

Nicola Lehners, MD, Christiane Heiss, Soh-Yun Kim, Thomas Hielscher, Jens Hillengass, MD, Gerlinde Egerer, MD, Anthony D. Ho, MD, Kai Neben, MD, Hartmut Goldschmidt, MD, Marc S. Raab, MD

Blood (2013) 122 (21): 3183.

https://doi.org/10.1182/blood.V122.21.3183.3183

Published: 2013

Journal Articles

Outbreak of Nosocomial Respiratory Syncytial Virus Infections in a Hematology and Transplant Unit.

Nicola Lehners, MD, Paul Schnitzler, MD, Gerlinde Egerer, MD, Peter Dreger, MD, Christoph Eisenbach, MD, Elisabeth Aichinger, MD, Benedikt Weißbrich, MD, Uwe Frank, MD, Klaus Heeg, MD, Anthony D Ho, MD

Blood (2012) 120 (21): 3032.

https://doi.org/10.1182/blood.V120.21.3032.3032

Published: 2012

Journal Articles

Autologous Re-Transplantation for Patients with Relapsed Multiple Myeloma: A Single Center Experience with 200 Patients.

Kai Neben, MD, Leopold Sellner, MD, Christiane Heiss, Dipl.Stat, Axel Benner, Dipl.Stat., Marc S Raab, MD, Jens Hillengass, MD, Dirk Hose, MD, PhD, Nicola Lehners, MD, Gerlinde Egerer, MD, Anthony D Ho, MD, Hartmut Goldschmidt, MD, PhD

Blood (2012) 120 (21): 3086.

https://doi.org/10.1182/blood.V120.21.3086.3086

Published: 2012

Journal Articles

Sequential High Dose Immuno-Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantation for Patients with Untreated Primary Central Nervous System Lymphoma - a Multicentre Study by the Collaborative PCNSL Study Group Freiburg

Blood (2012) 120 (21): 302.

https://doi.org/10.1182/blood.V120.21.302.302

Published: 2012

Journal Articles

Reapplication of High-Dose Chemotherapy with Melphalan Followed by Autologous Hematopoietic Stem Cell Transplantation as Salvage Therapy for Patients with Relapsed Multiple Myeloma

Leopold Sellner, MD, Sonja Teodorov, Christiane Heiss, Axel Benner, Gerlinde Egerer, MD, Peter Dreger, MD, Anthony D. Ho, MD, Hartmut Goldschmidt, MD, Kai Neben, MD

Blood (2010) 116 (21): 3568.

https://doi.org/10.1182/blood.V116.21.3568.3568

Published: 2010

Journal Articles

Correlation of Serological and MRI-Based Treatment Response to Systemic Chemotherapy In 100 Patients with Multiple Myeloma

Jens Hillengass, Sofia Ayyaz, Kerstin Kilk, Marc-André Weber, Thomas Hielscher, Gerlinde Egerer, Hans-Ulrich Kauczor, Stefan Delorme, Anthony D. Ho, MD, FRCPC, Hartmut Goldschmidt, Kai Neben

Blood (2010) 116 (21): 2977.

https://doi.org/10.1182/blood.V116.21.2977.2977

Published: 2010

Journal Articles

Achievement of CR and nCR Before and After First High-Dose Therapy Followed by Autologous Stem Cell Transplantation Is a Major Marker for Long-Term Survival in Multiple Myeloma Patients.

Hartmut Goldschmidt, Gerlinde Egerer, Ute Hegenbart, Markus Munder, Thomas Hielscher, Christiane Heiβ, Uta Bertsch, Jens Hillengaβ, Jana Schlenzka, Marc-Steffen Raab, Dirk Hose, Michael Hundemer, Kai Neben, Anthony D. Ho

Blood (2009) 114 (22): 3400.

https://doi.org/10.1182/blood.V114.22.3400.3400

Published: 2009

Journal Articles

Polychemotherapy in Combination with Thalidomide Followed by Autologous or Allogeneic Transplantation for Rescue after Autograft or Induction Therapy Failure in Patients with Multiple Myeloma.

Ute Hegenbart, MD, Stefan O. Schonland, MD, Thomas Moehler, MD, Axel Benner, PhD, Sabine Gerull, MD, Martin Goerner, MD, Hans-Joerg Schaefer, MD, Gerlinde Egerer, MD, Peter Dreger, MD, Anthony D. Ho, MD, Hartmut Goldschmidt, MD

Blood (2006) 108 (11): 3018.

https://doi.org/10.1182/blood.V108.11.3018.3018

Published: 2006

Journal Articles

Phase II Trial of the Bonn Polychemotherapy Protocol with Deferred Radiotherapy in Patients with Primary Central Nervous System Lymphoma.

Ingo G.H. Schmidt-Wolf, MD, Annika Juergens, MD, Hendrik Pels, MD, Axel Glasmacher, MD, Holger Schulz, MD, Andreas Engert, MD, Michael Linnebank, MD, Heinz Reichmann, MD, Frank Kroschinsky, MD, Marlies Vogt-Schaden, MD, Gerlinde Egerer, MD, Klaus Fliessbach, MD, Uwe Schlegel, MD

Blood (2006) 108 (11): 2453.

https://doi.org/10.1182/blood.V108.11.2453.2453

Published: 2006

NARROW

Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)

High-Dose Chemotherapy and Autologous Stem Cell Transplant in Elderly and Fit Primary CNS Lymphoma Patients - a Multicenter Study By the Cooperative PCNSL Study Group (MARTA study)

Prognostic Impact of Gastrointestinal Involvement in Newly Diagnosed Diffuse Large B-Cell Lymphoma

Characterization of Patients with Multiple Myeloma in Long- Term Remission

Analysis of Risk Factors Regarding Short- and Long-Term Mortality of Critically Ill Patients with Hematologic Malignancies or Following Stem Cell Transplantation Requiring Treatment on the Intensive Care Unit

Prognostic Impact of Extranodal Involvement in Newly Diagnosed Diffuse Large B-Cell Lymphoma

High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Support for Relapsed or Refractory Primary CNS Lymphoma - a Prospective Multicentre Trial By the German Cooperative PCNSL Study Group

Parainfluenza Virus Infections in Patients with Hematologic Malignancies or Following Stem Cell Transplantation: Analysis of Clinical Characteristics, Nosocomial Transmission and Prolonged Viral Shedding

Analysis of Prognostic Factors and Outcome of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma of the Gastrointestinal Tract

High Dose-Chemotherapy Followed By Autologous Peripheral Blood Stem Cell Transplantation for Patients with Refractory or Recurrent Primary Central Nervous System Lymphoma –Results of a Multicenter Study By the Germany Collaborative PCNSL Study Group

Rituximab, Age and High Dose Therapy Followed By Autologus Stem Cell Transplantation Are Independent Prognostic Factors for Survival in the First Line Treatment of Primary CNS-Lymphoma

Impact Of Response Duration and Maintenance Therapy After Autologous Stem Cell Transplantation On Long-Term Survival In Multiple Myeloma Patients

Outbreak of Nosocomial Respiratory Syncytial Virus Infections in a Hematology and Transplant Unit.

Autologous Re-Transplantation for Patients with Relapsed Multiple Myeloma: A Single Center Experience with 200 Patients.

Sequential High Dose Immuno-Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantation for Patients with Untreated Primary Central Nervous System Lymphoma - a Multicentre Study by the Collaborative PCNSL Study Group Freiburg

Reapplication of High-Dose Chemotherapy with Melphalan Followed by Autologous Hematopoietic Stem Cell Transplantation as Salvage Therapy for Patients with Relapsed Multiple Myeloma

Correlation of Serological and MRI-Based Treatment Response to Systemic Chemotherapy In 100 Patients with Multiple Myeloma

Achievement of CR and nCR Before and After First High-Dose Therapy Followed by Autologous Stem Cell Transplantation Is a Major Marker for Long-Term Survival in Multiple Myeloma Patients.

Polychemotherapy in Combination with Thalidomide Followed by Autologous or Allogeneic Transplantation for Rescue after Autograft or Induction Therapy Failure in Patients with Multiple Myeloma.

Phase II Trial of the Bonn Polychemotherapy Protocol with Deferred Radiotherapy in Patients with Primary Central Nervous System Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only